In addition to Drp1, LRRK2 interacts with Dlp1 to induce mitochondrial fragmentation [90,141], and levels of OPA1, a mitochondrial fusion protein, are reduced in brains of LRRK2 G2019S PD patients [147]. This evidence concerns the gene LRRK2 and Parkinson disease.